融合导航下经腰穿刺治疗II型内漏的多中心经验
该多中心回顾性研究评估了杂交手术室内应用术前CTA融合与术中锥形束CT导航经腰直接穿刺治疗主动脉腔内修复后II型内漏的疗效。26例患者接受治疗,随访平均214天,内漏复发率11.5%,无动脉瘤破裂,多数患者瘤囊缩小。
要点
- 融合导航经腰穿刺治疗II型内漏技术成功率高,复发率低。
- 术后多数患者瘤囊缩小,无动脉瘤破裂发生。
- 该技术可能较经动脉或经腔静脉栓塞更高效。
核心结论
- 融合图像引导经腰穿刺闭塞II型内漏在三个中心均有效,能显著缩小瘤囊。
研究设计与样本
- 多中心回顾性研究,纳入26例连续II型内漏患者,2015年3月至2017年9月在杂交手术室接受经腰穿刺治疗。
主要发现
- 所有26例患者(19男7女,年龄59-95岁)因瘤囊扩张或症状接受治疗,其中4例既往经导管治疗失败。
- 术后平均随访214天,19例瘤囊缩小(每100天0.2-19.1 mm),2例继续扩张(每100天3.4-4.3 mm),5例无变化。
- 内漏复发率为11.5%,研究期间无动脉瘤破裂。
- 手术时间75.9±40.7分钟,造影剂用量19.9±29 mL,透视时间13.74±12.2分钟,辐射剂量121.16±167.7 mGy。
- 单纯弹簧圈栓塞与弹簧圈联合Onyx或胶栓塞在无失败生存方面无差异(P > .05)。
临床怎么用
- 对于主动脉腔内修复后II型内漏伴瘤囊扩张或症状的患者,可考虑在杂交手术室采用融合导航经腰穿刺栓塞治疗。
局限性
- 样本量小(26例),随访时间短(平均214天),为回顾性多中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to evaluate the efficacy of treating type II endoleaks (T2Ls) after aortic endovascular repair with image guidance translumbar puncture using intraoperative cone beam computed tomography with preprocedure computed tomography angiography fusion in hybrid operating rooms. METHODS: Twenty-six consecutive T2L patients in three different institutions were treated between March 2015 and September 2017 by direct translumbar puncture of the abdominal aortic aneurysm (AAA) sac after previous endovascular aortic repair. All patients were treated at a single setting in a cardiovascular hybrid operating room with a workstation featuring needle trajectory planning and guidance software. Aneurysm sac size change from the index treatment, freedom from recurrent endoleak after treatment, demographics, risk factors, and procedure factors were analyzed with univariate analysis. RESULTS: All patients (N = 26; 19 male, 7 female; age range, 59-95 years; mean body mass index, 27.44 ± 3.06 kg/m2) underwent treatment for AAA sac expansion or symptoms. Four patients had failed to respond to previous catheter-directed T2L treatment. The most common risk factors included hypertension, hypercholesterolemia, coronary artery disease, tobacco use, and diabetes. Time to initial endoleak diagnosis ranged from 2 to 1914 days (average, 404 days). Aneurysm size after initial repair was 60.3 ± 7.5 mm; sac size had increased 10.1 ± 6.5 mm at the time of treatment. Onyx (Medtronic, Irvine, Calif) or glue (n-butyl cyanoacrylate) and coil embolization was used in 20 cases, and 6 patients were treated with coiling alone. There was no difference between the patients treated with coils alone and those treated with coils or glue (P > .05) in terms of freedom from failure. Total procedure time was 75.9 ± 40.7 minutes; contrast material volume, 19.9 ± 29 mL; fluoroscopy time, 13.74 ± 12.2 minutes; and radiation dose, 121.16 ± 167.7 mGy. After embolization, the mean sac diameter decreased by 2.2 mm to 67.5 ± 9.8 mm. Average follow-up period was 214 days. In 19 patients, the sac reduced in size between 0.2 and 19.1 mm per 100 days; in 2 patients, there was continued AAA expansion (3.4-4.3 mm per 100 days); there was no change in the sac size in 5 patients after the procedure. There were no AAA ruptures during the study period. Once T2L was treated, the recurrence rate was low at 11.5%. CONCLUSIONS: This initial multicenter evaluation of the effectiveness of fusion image-guided translumbar obliteration of T2L demonstrated that the technique was effective at all three study centers and showed excellent efficacy to reduce AAA sac size. This may become a more effective and efficient method of treating T2L compared with transarterial or transcaval embolization because of its high success rate and technical ease.
引用
- Rhee R, Oderich G, Hertault A, et al. Multicenter experience in translumbar type II endoleak treatment in the hybrid room with needle trajectory planning and fusion guidance. J Vasc Surg. 2019. PMID: 31882316. doi:10.1016/j.jvs.2019.10.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。